ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,536,000 | -3.6% | 4,841,591 | 0.0% | 100.00% | 0.0% |
| Q3 2020 | $6,778,000 | +94.4% | 4,841,591 | 0.0% | 100.00% | +1208.0% |
| Q2 2020 | $3,486,000 | +28.4% | 4,841,591 | 0.0% | 7.64% | +43.4% |
| Q1 2020 | $2,716,000 | -46.1% | 4,841,591 | 0.0% | 5.33% | +56.7% |
| Q4 2019 | $5,035,000 | -11.1% | 4,841,591 | 0.0% | 3.40% | -61.7% |
| Q3 2019 | $5,665,000 | -22.0% | 4,841,591 | 0.0% | 8.89% | +8.2% |
| Q2 2019 | $7,262,000 | +45.6% | 4,841,591 | 0.0% | 8.22% | +66.4% |
| Q1 2019 | $4,987,000 | -27.5% | 4,841,591 | 0.0% | 4.94% | -28.0% |
| Q4 2018 | $6,875,000 | -34.0% | 4,841,591 | 0.0% | 6.86% | -20.7% |
| Q3 2018 | $10,409,000 | +10.3% | 4,841,591 | 0.0% | 8.66% | +45.6% |
| Q2 2018 | $9,441,000 | +85.7% | 4,841,591 | 0.0% | 5.95% | +65.0% |
| Q1 2018 | $5,084,000 | +29.6% | 4,841,591 | 0.0% | 3.60% | +103.3% |
| Q4 2017 | $3,922,000 | – | 4,841,591 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|